tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Heron Therapeutics reports Q3 EPS (10c), consensus (1c)

Reports Q3 revenue $38.213M, consensus $39.03M. “There were a number of new initiatives launched in the third quarter, and we’re encouraged by the early signs that they’re positively impacting our commercial execution and driving increased demand for our products,” said Craig Collard, Chief Executive Officer of Heron.

Meet Your ETF AI Analyst

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1